Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management

CompletedOBSERVATIONAL
Enrollment

3,921

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Multidrug-resistant Bacteria Screening
Interventions
DIAGNOSTIC_TEST

molecular assays to screen for eXDR

"VRE detection will be performed using VIASURE Vancomycin resistance Real Time PCR Detection Kit.~BD MAX Check-Points CPO will be used to detect carbapenemase-producing organisms."

Trial Locations (1)

38043

Grenoble_Alpes UniversityHospital, Grenoble

Sponsors
All Listed Sponsors
collaborator

Becton, Dickinson and Company

INDUSTRY

lead

University Hospital, Grenoble

OTHER